Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $46.23 USD
Change Today -0.15 / -0.32%
Volume 709.2K
IPXL On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Carole S. Ben-Maimon M.D.

Former President of Global Pharmaceuticals Division, Impax Laboratories Inc.
AgeTotal Calculated CompensationThis person is connected to 12 board members in 1 different organizations across 4 different industries.

See Board Relationships
55$3,427,139
As of Fiscal Year 2014

Background*

Dr. Carole S. Ben-Maimon, M.D. served as the President of Global Pharmaceuticals Division at Impax Laboratories Inc. from September 6, 2011 to November 3, 2014. Dr. Ben-Maimon served as the President and Chief Executive Officer of Alita Pharmaceuticals, Inc. Prior to founding Alita Pharmaceuticals, Dr. Ben-Maimon served as the President & Chief Operating Officer of Duramed Research, the proprietary products research and development subsidiary of Barr Pharmaceuticals, ...

Read Full Background

Corporate Headquarters*

30831 Huntwood Avenue
Hayward, California 94544

United States

Phone: 510-476-2000
Fax: 510-240-6096

Board Members Memberships*

Former President of Global Pharmaceuticals Division
Director
President, Chief Executive Officer, and Director
2001-N/A
Former Director, President of Duramed Research Inc and Chief Operating Officer of Duramed Research Inc

Education*

Unknown/Other Education
Thomas Jefferson University School Of Medicine
BA
The University of Pennsylvania

Other Affiliations*

Annual Compensation*

Salary$458,022
Total Annual Compensation$458,022

Stock Options*

Restricted Stock Awards$580,520
All Other Compensation$1,351,249
Exercisable Options110,858
Exercisable Options Value$1,335,113
Total Value of Options$1,335,112
Total Number of Options110,858

Total Compensation*

Total Annual Cash Compensation$2,262,519
Total Short Term Compensation$458,022
Other Long Term Compensation$1,931,769
Total Calculated Compensation$3,427,139
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IPXL:US $46.23 USD -0.15

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Clive A. Meanwell M.D., Ph.D.Chairman and Chief Executive Officer
The Medicines Company
$874.6K
Pamela Louise Makin MA, Ph.D., MBAChief Executive Officer and Executive Director
BTG plc
1.0M GBP
Rajat Rai Chief Executive Officer
Akorn, Inc.
$1.1M
Arthur P. Bedrosian J.D.Chief Executive Officer, Director and Chairman of Strategic Planning Committee
Lannett Company, Inc.
$539.0K
Glenn Mario Saldanha Chairman of The Board, Chief Executive Officer, Managing Director, Member of Nomination & Remuneration Committee and Member of Shareholders/Investors Grievance Committee
Glenmark Pharmaceuticals Ltd.
57.1M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMPAX LABORATORIES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.